Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT00785213
- Locations
- 🇺🇸
Cetero Research, East Grand Forks, Minnesota, United States
Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2009-10-28
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00779259
- Locations
- 🇺🇸
PRACS Institute, Fargo, North Dakota, United States
A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00726414
A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00726895
A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT00727272
- Locations
- 🇺🇸
PRACS, Fargo, North Dakota, United States
Fed Bioavailability Study of Zonisamide Capsules
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2010-01-26
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT00687167
- Locations
- 🇺🇸
PRACS, Fargo, North Dakota, United States
Fasted Bioavailability Study of Cilostazol Tablets, 50mg
Phase 1
Completed
- Conditions
- Therapeutic Equivalency, Healthy
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2009-12-22
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00685802
Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2012-04-20
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT00684814
Fasting Bioavailability Study of Zonisamide Capsules
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2010-01-26
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT00685139
Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets
Phase 1
Completed
- Conditions
- Therapeutic Equivalency
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00685165
© Copyright 2025. All Rights Reserved by MedPath